This message was sent to ##Email##
|
|
|
|
|
| |
AST
The request for proposals is now open through November 1, 2017, for the 2018 research grant cycle. These career development grants are awarded to support the fellow or young independent investigator conducting a specific research project in any area of basic, clinical, or translational science.
READ MORE
AST
The Canadian Society of Transplantation and The Cell Transplant and Regenerative Medicine Society are pleased to co-host the 2017 CST-CTRMS Joint Scientific Meeting in Halifax, Nova Scotia from September 26 to 29, 2017 in the Halifax World Trade and Convention Centre. The AST will be hosting a breakfast symposium during this meeting. To learn more and register for this exciting event, please visit: http://www.cst-transplant.ca/2017_CST-CTRMS.html.
 |
|
Sanofi Genzyme provides benefit to patients by:
• Partnering with the community to increase access to transplant for appropriate patients
• Supporting patient advocacy and education
• Organ donation awareness initiatives
• Supporting clinicians to improve patient care
We define our success by the success of transplant patients
|
|
AST
Invite your colleagues to join AST for 2017! We’re making it easier for you to refer new members with our new, easy referral form! You can quickly send a personal and professional email message to refer your colleagues by clicking here. Be sure to share that new members who join during the months of July and August receive pro-rated dues!
For every new member successfully recruited, your name will be entered to win one of the following great prizes:
- iPad and free membership for 2018
- $500 AST bucks
- $250 AST bucks
To view all 2016-2017 Member-Get-A-Member (previously Pay it Forward) participants, click here.
Spread the word! Recommend colleagues for membership through the 2017-2018 year and get your chance to win! Visit the Member-Get-A-Member page for program details and more!
READ MORE
AST
Registration for the AST Fellows Symposium will close on July 26, 2017 at 12:01 AM EST. The meeting will be held September 15-17, 2017, in Grapevine, TX.
READ MORE
ASN
Join ASN and more than 13,000 other kidney professionals from across the globe at Kidney Week 2017 in New Orleans, LA. The world's premier nephrology meeting, Kidney Week provides participants exciting and challenging opportunities to exchange knowledge, learn the latest scientific and medical advances, and listen to engaging and provocative discussions with leading experts in the field.
READ MORE
AST
Check out AST's archived webinars and journal clubs, and watch educational content when it's convenient for you. The AST also offers a variety of resources for different transplant specialties, all available on our easy-to-search website.
AST
"Gene Expression Profiling for the Identification and Classification of Antibody-Mediated Heart Rejection"
AST
July 20, 2017 | 2 p.m ET | Online activity
For more information: https://www.myast.org/education/astajt-journal-club
Liver Transplantation
Hepatic steatosis develops after liver transplantation (LT) in 30 percent of adults, and nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease in nontransplanted children. However, posttransplant steatosis has been minimally studied in pediatric LT recipients.
READ MORE
Liver Transplantation
The purpose of this study was to evaluate the feasibility of living donor liver transplantation for treatment of patients with hepatocellular carcinoma and segmental portal vein tumor thrombus (PVTT) below the second-order branch. Between January 2005 and December 2015, we retrospectively analyzed 242 patients in a control group (n = 184), a microvascular invasion (MVI) group (n = 24), and a PVTT group (n = 34).
READ MORE
American Journal of Transplantation
Previous studies have grouped all donors positive for hepatitis C virus (HCV) antibody (Ab). Only recently has donor HCV nucleic acid testing (NAT) become routine, and the impact of Ab and NAT status on organ utilization is unknown. Using the United Network for Organ Sharing database, we identified 9290 donors from 2015 to 2016 for whom both HCV Ab and NAT data were available and compared organ utilization by HCV status.
READ MORE
American Journal of Transplantation
Belatacept, a T cell costimulation blocker, demonstrated superior renal function, lower cardiovascular risk, and improved graft and patient survival in renal transplant recipients. Despite the potential benefits, adoption of belatacept has been limited in part due to concerns regarding higher rates and grades of acute rejection in clinical trials. Since July 2011, we have utilized belatacept-based immunosuppression regimens in clinical practice.
READ MORE
American Journal of Transplantation
Organ transplantation is the most successful treatment for some forms of organ failure, yet a lack of organs means many die on the waiting list. In the United Kingdom, the Organ Donation Taskforce was set up to identify barriers to organ donation and in 2008 released its first report (Organ Donation Taskforce Report; ODTR). This study assesses the success since the ODTR and examines the impact of the United Kingdom's controlled donation after circulatory death (DCD) program and the controversies surrounding it.
READ MORE
|
|
|
|
7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063
|
